Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
2025 Standout
Targeting KRAS: from metabolic regulation to cancer treatment
2025 Standout
Works of Karen Carty being referenced
A randomized phase II/III study to assess the efficacy of trametinib in patients with recurrent or progressive low-grade serous ovarian or peritoneal cancer
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Karen Carty | 121 | 46 | 86 | 144 | 89 | 18 | 359 | |
| Tsuneo Fujii | 94 | 28 | 37 | 78 | 105 | 24 | 359 | |
| C Midulla | 118 | 20 | 46 | 105 | 64 | 19 | 368 | |
| Suzie E. Ahn | 65 | 27 | 18 | 117 | 54 | 15 | 354 | |
| Diana Lim | 71 | 28 | 17 | 179 | 71 | 19 | 322 | |
| Jean Rousseaux | 44 | 16 | 28 | 136 | 13 | 22 | 395 | |
| Adriana Fortunato | 120 | 9 | 21 | 121 | 14 | 26 | 381 | |
| Valentina Lacconi | 76 | 19 | 69 | 92 | 40 | 18 | 397 | |
| Kamila Chagas Peronni | 31 | 7 | 28 | 135 | 29 | 23 | 315 | |
| Qizhi Cao | 32 | 50 | 8 | 85 | 46 | 24 | 365 | |
| M. Gambacorta | 75 | 44 | 6 | 65 | 100 | 19 | 394 |
All Works
Login with ORCID to disown or claim papers
Loading papers...